nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—PTGS2—Naproxen—gout	0.114	0.169	CbGbCtD
Thalidomide—PTGS1—Naproxen—gout	0.0966	0.143	CbGbCtD
Thalidomide—PTGS2—Indomethacin—gout	0.0756	0.112	CbGbCtD
Thalidomide—PTGS1—Indomethacin—gout	0.0638	0.0944	CbGbCtD
Thalidomide—CYP2E1—Colchicine—gout	0.0566	0.0837	CbGbCtD
Thalidomide—CYP1A2—Naproxen—gout	0.0432	0.0638	CbGbCtD
Thalidomide—CYP2C9—Naproxen—gout	0.0389	0.0575	CbGbCtD
Thalidomide—CYP2C19—Probenecid—gout	0.0317	0.047	CbGbCtD
Thalidomide—CYP2C19—Indomethacin—gout	0.0309	0.0457	CbGbCtD
Thalidomide—CYP2C9—Colchicine—gout	0.0295	0.0436	CbGbCtD
Thalidomide—CYP2C9—Probenecid—gout	0.0264	0.039	CbGbCtD
Thalidomide—CYP2C9—Indomethacin—gout	0.0257	0.038	CbGbCtD
Thalidomide—CYP3A5—Hydrocortisone—gout	0.0236	0.0349	CbGbCtD
Thalidomide—CYP2C19—Prednisone—gout	0.019	0.0281	CbGbCtD
Thalidomide—NFKB1—Interleukin-1 processing—CASP1—gout	0.00467	0.116	CbGpPWpGaD
Thalidomide—NFKB1—Inflammasomes—NLRP3—gout	0.00413	0.103	CbGpPWpGaD
Thalidomide—NFKB1—IL1 and megakaryotyces in obesity—NLRP3—gout	0.00357	0.0889	CbGpPWpGaD
Thalidomide—NFKB1—Inflammasomes—CASP1—gout	0.00202	0.0503	CbGpPWpGaD
Thalidomide—NFKB1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NLRP3—gout	0.00198	0.0494	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—IL15—gout	0.0019	0.0474	CbGpPWpGaD
Thalidomide—TNF—Cellular roles of Anthrax toxin—CASP1—gout	0.00142	0.0355	CbGpPWpGaD
Thalidomide—PTGS2—Fluocinonide—Methylprednisolone—gout	0.00137	0.624	CbGdCrCtD
Thalidomide—CYP3A5—Irinotecan Pathway—ABCG2—gout	0.00136	0.0339	CbGpPWpGaD
Thalidomide—NFKB1—IL1-mediated signaling events—CASP1—gout	0.00132	0.0329	CbGpPWpGaD
Thalidomide—NFKB1—IL1-mediated signaling events—IL1RN—gout	0.00128	0.0318	CbGpPWpGaD
Thalidomide—NFKB1—Interleukin-1 signaling—IL1RN—gout	0.00112	0.028	CbGpPWpGaD
Thalidomide—NFKB1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP1—gout	0.000969	0.0241	CbGpPWpGaD
Thalidomide—TNF—Amyotrophic lateral sclerosis (ALS)—CASP1—gout	0.000919	0.0229	CbGpPWpGaD
Thalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—gout	0.000824	0.376	CbGdCrCtD
Thalidomide—NFKB1—Leptin signaling pathway—IL1RN—gout	0.000678	0.0169	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis—CASP1—gout	0.00064	0.0159	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis Modulation and Signaling—CASP1—gout	0.0006	0.015	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—CASP1—gout	0.000523	0.013	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—IL1RN—gout	0.000507	0.0126	CbGpPWpGaD
Thalidomide—TNF—Apoptosis—CASP1—gout	0.000487	0.0121	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—IL1RN—gout	0.000378	0.00941	CbGpPWpGaD
Thalidomide—NFKB1—MAPK Signaling Pathway—CASP1—gout	0.000367	0.00916	CbGpPWpGaD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—POMC—gout	0.00032	0.00796	CbGpPWpGaD
Thalidomide—NFKB1—Corticotropin-releasing hormone—POMC—gout	0.000291	0.00726	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—IL1RN—gout	0.000288	0.00717	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—NLRP3—gout	0.00028	0.00699	CbGpPWpGaD
Thalidomide—TNF—MAPK Signaling Pathway—CASP1—gout	0.00028	0.00698	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—NLRP3—gout	0.000266	0.00663	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—CASP1—gout	0.000244	0.00609	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL1RN—gout	0.000236	0.00589	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PRPS1—gout	0.000216	0.00538	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PRPS2—gout	0.000216	0.00538	CbGpPWpGaD
Thalidomide—PTGS1—Phase 1 - Functionalization of compounds—POMC—gout	0.000197	0.00492	CbGpPWpGaD
Thalidomide—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000182	0.00454	CbGpPWpGaD
Thalidomide—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000182	0.00453	CbGpPWpGaD
Thalidomide—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000172	0.00428	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—NLRP3—gout	0.000163	0.00407	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—NLRP3—gout	0.000155	0.00386	CbGpPWpGaD
Thalidomide—CYP2E1—Phase 1 - Functionalization of compounds—POMC—gout	0.000148	0.00368	CbGpPWpGaD
Thalidomide—CYP3A5—Phase 1 - Functionalization of compounds—POMC—gout	0.000147	0.00367	CbGpPWpGaD
Thalidomide—Myocardial infarction—Prednisolone—gout	0.000146	0.000517	CcSEcCtD
Thalidomide—Neuropathy peripheral—Prednisolone—gout	0.000146	0.000517	CcSEcCtD
Thalidomide—Purpura—Prednisone—gout	0.000145	0.000516	CcSEcCtD
Thalidomide—Infestation NOS—Hydrocortisone—gout	0.000145	0.000515	CcSEcCtD
Thalidomide—Infestation—Hydrocortisone—gout	0.000145	0.000515	CcSEcCtD
Thalidomide—Pruritus—Allopurinol—gout	0.000145	0.000513	CcSEcCtD
Thalidomide—Conjunctivitis—Prednisolone—gout	0.000144	0.000513	CcSEcCtD
Thalidomide—Cardiac failure—Prednisone—gout	0.000144	0.00051	CcSEcCtD
Thalidomide—Vomiting—Indomethacin—gout	0.000143	0.000509	CcSEcCtD
Thalidomide—Acute coronary syndrome—Hydrocortisone—gout	0.000143	0.000508	CcSEcCtD
Thalidomide—Lethargy—Prednisone—gout	0.000143	0.000508	CcSEcCtD
Thalidomide—Neuropathy peripheral—Hydrocortisone—gout	0.000142	0.000505	CcSEcCtD
Thalidomide—Myocardial infarction—Hydrocortisone—gout	0.000142	0.000505	CcSEcCtD
Thalidomide—Rash—Indomethacin—gout	0.000142	0.000504	CcSEcCtD
Thalidomide—Dermatitis—Indomethacin—gout	0.000142	0.000504	CcSEcCtD
Thalidomide—Urticaria—Naproxen—gout	0.000142	0.000503	CcSEcCtD
Thalidomide—Headache—Indomethacin—gout	0.000141	0.000501	CcSEcCtD
Thalidomide—Abdominal pain—Naproxen—gout	0.000141	0.000501	CcSEcCtD
Thalidomide—Body temperature increased—Naproxen—gout	0.000141	0.000501	CcSEcCtD
Thalidomide—Nausea—Colchicine—gout	0.000141	0.0005	CcSEcCtD
Thalidomide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—gout	0.00014	0.0035	CbGpPWpGaD
Thalidomide—Gastrointestinal haemorrhage—Prednisone—gout	0.00014	0.000498	CcSEcCtD
Thalidomide—Osteoarthritis—Prednisone—gout	0.00014	0.000498	CcSEcCtD
Thalidomide—Diarrhoea—Allopurinol—gout	0.00014	0.000497	CcSEcCtD
Thalidomide—Weight increased—Methylprednisolone—gout	0.000139	0.000494	CcSEcCtD
Thalidomide—CYP1A1—Phase 1 - Functionalization of compounds—POMC—gout	0.000139	0.00347	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—BCKDHA—gout	0.000139	0.00346	CbGpPWpGaD
Thalidomide—Affect lability—Prednisone—gout	0.000138	0.00049	CcSEcCtD
Thalidomide—NFKB1—Innate Immune System—CASP1—gout	0.000137	0.00341	CbGpPWpGaD
Thalidomide—Psychotic disorder—Prednisone—gout	0.000137	0.000486	CcSEcCtD
Thalidomide—Infestation—Methylprednisolone—gout	0.000136	0.000484	CcSEcCtD
Thalidomide—Infestation NOS—Methylprednisolone—gout	0.000136	0.000484	CcSEcCtD
Thalidomide—Bradycardia—Prednisolone—gout	0.000136	0.000482	CcSEcCtD
Thalidomide—Face oedema—Prednisone—gout	0.000135	0.00048	CcSEcCtD
Thalidomide—Dizziness—Allopurinol—gout	0.000135	0.00048	CcSEcCtD
Thalidomide—Acute coronary syndrome—Methylprednisolone—gout	0.000134	0.000477	CcSEcCtD
Thalidomide—Nausea—Indomethacin—gout	0.000134	0.000475	CcSEcCtD
Thalidomide—Myocardial infarction—Methylprednisolone—gout	0.000134	0.000475	CcSEcCtD
Thalidomide—Neuropathy peripheral—Methylprednisolone—gout	0.000134	0.000475	CcSEcCtD
Thalidomide—Cardiac arrest—Prednisone—gout	0.000133	0.000473	CcSEcCtD
Thalidomide—Mood swings—Prednisone—gout	0.000133	0.000471	CcSEcCtD
Thalidomide—Bradycardia—Hydrocortisone—gout	0.000133	0.000471	CcSEcCtD
Thalidomide—Hypersensitivity—Naproxen—gout	0.000131	0.000467	CcSEcCtD
Thalidomide—Sweating—Methylprednisolone—gout	0.000131	0.000464	CcSEcCtD
Thalidomide—Vomiting—Allopurinol—gout	0.00013	0.000461	CcSEcCtD
Thalidomide—FGFR2—Innate Immune System—CASP1—gout	0.00013	0.00324	CbGpPWpGaD
Thalidomide—Rash—Allopurinol—gout	0.000129	0.000458	CcSEcCtD
Thalidomide—Dermatitis—Allopurinol—gout	0.000129	0.000457	CcSEcCtD
Thalidomide—Visual impairment—Prednisolone—gout	0.000129	0.000456	CcSEcCtD
Thalidomide—Dry skin—Prednisone—gout	0.000128	0.000456	CcSEcCtD
Thalidomide—Headache—Allopurinol—gout	0.000128	0.000455	CcSEcCtD
Thalidomide—Asthenia—Naproxen—gout	0.000128	0.000455	CcSEcCtD
Thalidomide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000128	0.00319	CbGpPWpGaD
Thalidomide—Hypokalaemia—Prednisone—gout	0.000128	0.000453	CcSEcCtD
Thalidomide—Pruritus—Naproxen—gout	0.000126	0.000448	CcSEcCtD
Thalidomide—Bradycardia—Methylprednisolone—gout	0.000125	0.000442	CcSEcCtD
Thalidomide—Alanine aminotransferase increased—Prednisone—gout	0.000124	0.000439	CcSEcCtD
Thalidomide—Muscular weakness—Prednisone—gout	0.000124	0.000439	CcSEcCtD
Thalidomide—Rhinitis—Methylprednisolone—gout	0.000123	0.000436	CcSEcCtD
Thalidomide—Diarrhoea—Naproxen—gout	0.000122	0.000434	CcSEcCtD
Thalidomide—Abdominal distension—Prednisone—gout	0.000122	0.000433	CcSEcCtD
Thalidomide—Eye disorder—Hydrocortisone—gout	0.000122	0.000432	CcSEcCtD
Thalidomide—Nausea—Allopurinol—gout	0.000121	0.000431	CcSEcCtD
Thalidomide—Arrhythmia—Prednisolone—gout	0.000119	0.000423	CcSEcCtD
Thalidomide—Pancreatitis—Prednisone—gout	0.000119	0.000422	CcSEcCtD
Thalidomide—Dizziness—Naproxen—gout	0.000118	0.000419	CcSEcCtD
Thalidomide—Visual impairment—Methylprednisolone—gout	0.000118	0.000419	CcSEcCtD
Thalidomide—Immune system disorder—Hydrocortisone—gout	0.000118	0.000418	CcSEcCtD
Thalidomide—Arrhythmia—Hydrocortisone—gout	0.000116	0.000413	CcSEcCtD
Thalidomide—Eye disorder—Methylprednisolone—gout	0.000114	0.000406	CcSEcCtD
Thalidomide—Mental disorder—Hydrocortisone—gout	0.000114	0.000405	CcSEcCtD
Thalidomide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—gout	0.000114	0.00284	CbGpPWpGaD
Thalidomide—Cardiac disorder—Methylprednisolone—gout	0.000114	0.000403	CcSEcCtD
Thalidomide—Vomiting—Naproxen—gout	0.000113	0.000403	CcSEcCtD
Thalidomide—Malnutrition—Hydrocortisone—gout	0.000113	0.000403	CcSEcCtD
Thalidomide—Neutropenia—Prednisone—gout	0.000113	0.000402	CcSEcCtD
Thalidomide—PTGS1—Metabolism—HPRT1—gout	0.000113	0.00282	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PRPS2—gout	0.000113	0.00282	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PRPS1—gout	0.000113	0.00282	CbGpPWpGaD
Thalidomide—Rash—Naproxen—gout	0.000113	0.0004	CcSEcCtD
Thalidomide—Dermatitis—Naproxen—gout	0.000112	0.000399	CcSEcCtD
Thalidomide—Headache—Naproxen—gout	0.000112	0.000397	CcSEcCtD
Thalidomide—Erectile dysfunction—Prednisone—gout	0.000112	0.000396	CcSEcCtD
Thalidomide—Angiopathy—Methylprednisolone—gout	0.000111	0.000394	CcSEcCtD
Thalidomide—Immune system disorder—Methylprednisolone—gout	0.000111	0.000393	CcSEcCtD
Thalidomide—Mediastinal disorder—Methylprednisolone—gout	0.00011	0.000392	CcSEcCtD
Thalidomide—Weight increased—Prednisone—gout	0.00011	0.000391	CcSEcCtD
Thalidomide—PTGS2—Metabolism—BCKDHA—gout	0.00011	0.00275	CbGpPWpGaD
Thalidomide—Weight decreased—Prednisone—gout	0.00011	0.000389	CcSEcCtD
Thalidomide—Vision blurred—Prednisolone—gout	0.000109	0.000389	CcSEcCtD
Thalidomide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000109	0.00273	CbGpPWpGaD
Thalidomide—Arrhythmia—Methylprednisolone—gout	0.000109	0.000388	CcSEcCtD
Thalidomide—Hyperglycaemia—Prednisone—gout	0.000109	0.000388	CcSEcCtD
Thalidomide—Ill-defined disorder—Prednisolone—gout	0.000108	0.000383	CcSEcCtD
Thalidomide—Depression—Prednisone—gout	0.000108	0.000382	CcSEcCtD
Thalidomide—PTGS2—Disease—PRPS2—gout	0.000107	0.00267	CbGpPWpGaD
Thalidomide—PTGS2—Disease—PRPS1—gout	0.000107	0.00267	CbGpPWpGaD
Thalidomide—Mental disorder—Methylprednisolone—gout	0.000107	0.000381	CcSEcCtD
Thalidomide—Malnutrition—Methylprednisolone—gout	0.000107	0.000378	CcSEcCtD
Thalidomide—Acute coronary syndrome—Prednisone—gout	0.000106	0.000378	CcSEcCtD
Thalidomide—Angioedema—Prednisolone—gout	0.000106	0.000377	CcSEcCtD
Thalidomide—Nausea—Naproxen—gout	0.000106	0.000376	CcSEcCtD
Thalidomide—Myocardial infarction—Prednisone—gout	0.000106	0.000376	CcSEcCtD
Thalidomide—Neuropathy peripheral—Prednisone—gout	0.000106	0.000376	CcSEcCtD
Thalidomide—Ill-defined disorder—Hydrocortisone—gout	0.000105	0.000374	CcSEcCtD
Thalidomide—PTGS1—Biological oxidations—POMC—gout	0.000105	0.00261	CbGpPWpGaD
Thalidomide—Malaise—Prednisolone—gout	0.000105	0.000372	CcSEcCtD
Thalidomide—Vertigo—Prednisolone—gout	0.000104	0.00037	CcSEcCtD
Thalidomide—Syncope—Prednisolone—gout	0.000104	0.00037	CcSEcCtD
Thalidomide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—gout	0.000104	0.00259	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—BCKDHA—gout	0.000104	0.00259	CbGpPWpGaD
Thalidomide—Angioedema—Hydrocortisone—gout	0.000104	0.000368	CcSEcCtD
Thalidomide—CYP3A5—Metabolism—BCKDHA—gout	0.000104	0.00258	CbGpPWpGaD
Thalidomide—Malaise—Hydrocortisone—gout	0.000102	0.000363	CcSEcCtD
Thalidomide—Loss of consciousness—Prednisolone—gout	0.000102	0.000362	CcSEcCtD
Thalidomide—Vertigo—Hydrocortisone—gout	0.000102	0.000362	CcSEcCtD
Thalidomide—Syncope—Hydrocortisone—gout	0.000102	0.000361	CcSEcCtD
Thalidomide—Convulsion—Prednisolone—gout	0.000101	0.000357	CcSEcCtD
Thalidomide—Hypertension—Prednisolone—gout	0.0001	0.000356	CcSEcCtD
Thalidomide—Loss of consciousness—Hydrocortisone—gout	9.97e-05	0.000354	CcSEcCtD
Thalidomide—Ill-defined disorder—Methylprednisolone—gout	9.89e-05	0.000351	CcSEcCtD
Thalidomide—Bradycardia—Prednisone—gout	9.87e-05	0.00035	CcSEcCtD
Thalidomide—Convulsion—Hydrocortisone—gout	9.83e-05	0.000349	CcSEcCtD
Thalidomide—Hypertension—Hydrocortisone—gout	9.79e-05	0.000348	CcSEcCtD
Thalidomide—CYP1A1—Metabolism—BCKDHA—gout	9.78e-05	0.00244	CbGpPWpGaD
Thalidomide—Discomfort—Prednisolone—gout	9.77e-05	0.000347	CcSEcCtD
Thalidomide—Angioedema—Methylprednisolone—gout	9.74e-05	0.000346	CcSEcCtD
Thalidomide—Myalgia—Hydrocortisone—gout	9.65e-05	0.000343	CcSEcCtD
Thalidomide—Anxiety—Hydrocortisone—gout	9.62e-05	0.000342	CcSEcCtD
Thalidomide—Malaise—Methylprednisolone—gout	9.61e-05	0.000341	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	9.59e-05	0.00034	CcSEcCtD
Thalidomide—Vertigo—Methylprednisolone—gout	9.57e-05	0.00034	CcSEcCtD
Thalidomide—Syncope—Methylprednisolone—gout	9.55e-05	0.000339	CcSEcCtD
Thalidomide—Discomfort—Hydrocortisone—gout	9.54e-05	0.000339	CcSEcCtD
Thalidomide—Oedema—Prednisolone—gout	9.48e-05	0.000336	CcSEcCtD
Thalidomide—Loss of consciousness—Methylprednisolone—gout	9.36e-05	0.000333	CcSEcCtD
Thalidomide—Shock—Prednisolone—gout	9.32e-05	0.000331	CcSEcCtD
Thalidomide—Oedema—Hydrocortisone—gout	9.26e-05	0.000329	CcSEcCtD
Thalidomide—Tachycardia—Prednisolone—gout	9.25e-05	0.000328	CcSEcCtD
Thalidomide—Convulsion—Methylprednisolone—gout	9.23e-05	0.000328	CcSEcCtD
Thalidomide—Hypertension—Methylprednisolone—gout	9.2e-05	0.000327	CcSEcCtD
Thalidomide—Infection—Hydrocortisone—gout	9.19e-05	0.000326	CcSEcCtD
Thalidomide—Hyperhidrosis—Prednisolone—gout	9.16e-05	0.000325	CcSEcCtD
Thalidomide—Shock—Hydrocortisone—gout	9.11e-05	0.000323	CcSEcCtD
Thalidomide—Nervous system disorder—Hydrocortisone—gout	9.08e-05	0.000322	CcSEcCtD
Thalidomide—Arthralgia—Methylprednisolone—gout	9.07e-05	0.000322	CcSEcCtD
Thalidomide—Myalgia—Methylprednisolone—gout	9.07e-05	0.000322	CcSEcCtD
Thalidomide—Eye disorder—Prednisone—gout	9.06e-05	0.000322	CcSEcCtD
Thalidomide—Anxiety—Methylprednisolone—gout	9.04e-05	0.000321	CcSEcCtD
Thalidomide—Tachycardia—Hydrocortisone—gout	9.03e-05	0.000321	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	9.01e-05	0.00032	CcSEcCtD
Thalidomide—Skin disorder—Hydrocortisone—gout	8.99e-05	0.000319	CcSEcCtD
Thalidomide—PTGS2—Metabolism—PRPS2—gout	8.98e-05	0.00224	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PRPS1—gout	8.98e-05	0.00224	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—HPRT1—gout	8.98e-05	0.00224	CbGpPWpGaD
Thalidomide—Discomfort—Methylprednisolone—gout	8.96e-05	0.000318	CcSEcCtD
Thalidomide—Hyperhidrosis—Hydrocortisone—gout	8.95e-05	0.000318	CcSEcCtD
Thalidomide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—gout	8.87e-05	0.00221	CbGpPWpGaD
Thalidomide—Anorexia—Hydrocortisone—gout	8.82e-05	0.000313	CcSEcCtD
Thalidomide—Angiopathy—Prednisone—gout	8.79e-05	0.000312	CcSEcCtD
Thalidomide—Confusional state—Methylprednisolone—gout	8.77e-05	0.000311	CcSEcCtD
Thalidomide—Immune system disorder—Prednisone—gout	8.75e-05	0.000311	CcSEcCtD
Thalidomide—Arrhythmia—Prednisone—gout	8.66e-05	0.000307	CcSEcCtD
Thalidomide—Hypotension—Hydrocortisone—gout	8.65e-05	0.000307	CcSEcCtD
Thalidomide—Infection—Methylprednisolone—gout	8.64e-05	0.000307	CcSEcCtD
Thalidomide—Insomnia—Prednisolone—gout	8.57e-05	0.000304	CcSEcCtD
Thalidomide—Alopecia—Prednisone—gout	8.57e-05	0.000304	CcSEcCtD
Thalidomide—Shock—Methylprednisolone—gout	8.55e-05	0.000304	CcSEcCtD
Thalidomide—Nervous system disorder—Methylprednisolone—gout	8.53e-05	0.000303	CcSEcCtD
Thalidomide—Paraesthesia—Prednisolone—gout	8.51e-05	0.000302	CcSEcCtD
Thalidomide—Mental disorder—Prednisone—gout	8.49e-05	0.000302	CcSEcCtD
Thalidomide—Tachycardia—Methylprednisolone—gout	8.49e-05	0.000301	CcSEcCtD
Thalidomide—CYP2E1—Metabolism—PRPS1—gout	8.46e-05	0.00211	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—HPRT1—gout	8.46e-05	0.00211	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PRPS2—gout	8.46e-05	0.00211	CbGpPWpGaD
Thalidomide—Skin disorder—Methylprednisolone—gout	8.45e-05	0.0003	CcSEcCtD
Thalidomide—CYP3A5—Metabolism—PRPS1—gout	8.44e-05	0.0021	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—HPRT1—gout	8.44e-05	0.0021	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PRPS2—gout	8.44e-05	0.0021	CbGpPWpGaD
Thalidomide—Malnutrition—Prednisone—gout	8.44e-05	0.0003	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Hydrocortisone—gout	8.43e-05	0.000299	CcSEcCtD
Thalidomide—Hyperhidrosis—Methylprednisolone—gout	8.41e-05	0.000298	CcSEcCtD
Thalidomide—Insomnia—Hydrocortisone—gout	8.37e-05	0.000297	CcSEcCtD
Thalidomide—Paraesthesia—Hydrocortisone—gout	8.31e-05	0.000295	CcSEcCtD
Thalidomide—Dyspepsia—Hydrocortisone—gout	8.15e-05	0.000289	CcSEcCtD
Thalidomide—Hypotension—Methylprednisolone—gout	8.13e-05	0.000289	CcSEcCtD
Thalidomide—Pain—Prednisolone—gout	8.1e-05	0.000288	CcSEcCtD
Thalidomide—Decreased appetite—Hydrocortisone—gout	8.05e-05	0.000286	CcSEcCtD
Thalidomide—CYP2C19—Metabolism—BCKDHA—gout	8e-05	0.00199	CbGpPWpGaD
Thalidomide—Gastrointestinal disorder—Hydrocortisone—gout	7.99e-05	0.000284	CcSEcCtD
Thalidomide—Fatigue—Hydrocortisone—gout	7.98e-05	0.000283	CcSEcCtD
Thalidomide—NFKB1—Immune System—CASP1—gout	7.98e-05	0.00199	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—HPRT1—gout	7.97e-05	0.00199	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PRPS1—gout	7.97e-05	0.00199	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PRPS2—gout	7.97e-05	0.00199	CbGpPWpGaD
Thalidomide—Vision blurred—Prednisone—gout	7.95e-05	0.000282	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Methylprednisolone—gout	7.92e-05	0.000281	CcSEcCtD
Thalidomide—Pain—Hydrocortisone—gout	7.91e-05	0.000281	CcSEcCtD
Thalidomide—Insomnia—Methylprednisolone—gout	7.86e-05	0.000279	CcSEcCtD
Thalidomide—CYP2E1—Biological oxidations—POMC—gout	7.84e-05	0.00195	CbGpPWpGaD
Thalidomide—Ill-defined disorder—Prednisone—gout	7.83e-05	0.000278	CcSEcCtD
Thalidomide—CYP3A5—Biological oxidations—POMC—gout	7.82e-05	0.00195	CbGpPWpGaD
Thalidomide—Feeling abnormal—Prednisolone—gout	7.81e-05	0.000277	CcSEcCtD
Thalidomide—Paraesthesia—Methylprednisolone—gout	7.81e-05	0.000277	CcSEcCtD
Thalidomide—Anaemia—Prednisone—gout	7.8e-05	0.000277	CcSEcCtD
Thalidomide—Agitation—Prednisone—gout	7.75e-05	0.000275	CcSEcCtD
Thalidomide—NFKB1—Immune System—IL1RN—gout	7.72e-05	0.00193	CbGpPWpGaD
Thalidomide—Angioedema—Prednisone—gout	7.71e-05	0.000274	CcSEcCtD
Thalidomide—Dyspepsia—Methylprednisolone—gout	7.65e-05	0.000272	CcSEcCtD
Thalidomide—Feeling abnormal—Hydrocortisone—gout	7.63e-05	0.000271	CcSEcCtD
Thalidomide—Malaise—Prednisone—gout	7.61e-05	0.00027	CcSEcCtD
Thalidomide—Vertigo—Prednisone—gout	7.58e-05	0.000269	CcSEcCtD
Thalidomide—Gastrointestinal pain—Hydrocortisone—gout	7.57e-05	0.000269	CcSEcCtD
Thalidomide—FGFR2—Immune System—CASP1—gout	7.57e-05	0.00189	CbGpPWpGaD
Thalidomide—Syncope—Prednisone—gout	7.57e-05	0.000269	CcSEcCtD
Thalidomide—Urticaria—Prednisolone—gout	7.53e-05	0.000267	CcSEcCtD
Thalidomide—Fatigue—Methylprednisolone—gout	7.5e-05	0.000266	CcSEcCtD
Thalidomide—Loss of consciousness—Prednisone—gout	7.42e-05	0.000263	CcSEcCtD
Thalidomide—CYP1A1—Biological oxidations—POMC—gout	7.39e-05	0.00184	CbGpPWpGaD
Thalidomide—Urticaria—Hydrocortisone—gout	7.35e-05	0.000261	CcSEcCtD
Thalidomide—FGFR2—Immune System—IL1RN—gout	7.33e-05	0.00183	CbGpPWpGaD
Thalidomide—Abdominal pain—Hydrocortisone—gout	7.32e-05	0.00026	CcSEcCtD
Thalidomide—Body temperature increased—Hydrocortisone—gout	7.32e-05	0.00026	CcSEcCtD
Thalidomide—Convulsion—Prednisone—gout	7.31e-05	0.00026	CcSEcCtD
Thalidomide—CYP2C9—Metabolism—BCKDHA—gout	7.3e-05	0.00182	CbGpPWpGaD
Thalidomide—Hypertension—Prednisone—gout	7.28e-05	0.000259	CcSEcCtD
Thalidomide—Arthralgia—Prednisone—gout	7.18e-05	0.000255	CcSEcCtD
Thalidomide—Myalgia—Prednisone—gout	7.18e-05	0.000255	CcSEcCtD
Thalidomide—Feeling abnormal—Methylprednisolone—gout	7.17e-05	0.000254	CcSEcCtD
Thalidomide—Anxiety—Prednisone—gout	7.16e-05	0.000254	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	7.13e-05	0.000253	CcSEcCtD
Thalidomide—Gastrointestinal pain—Methylprednisolone—gout	7.11e-05	0.000252	CcSEcCtD
Thalidomide—Discomfort—Prednisone—gout	7.1e-05	0.000252	CcSEcCtD
Thalidomide—Hypersensitivity—Prednisolone—gout	6.98e-05	0.000248	CcSEcCtD
Thalidomide—Urticaria—Methylprednisolone—gout	6.91e-05	0.000245	CcSEcCtD
Thalidomide—Oedema—Prednisone—gout	6.89e-05	0.000245	CcSEcCtD
Thalidomide—Abdominal pain—Methylprednisolone—gout	6.87e-05	0.000244	CcSEcCtD
Thalidomide—Infection—Prednisone—gout	6.84e-05	0.000243	CcSEcCtD
Thalidomide—Hypersensitivity—Hydrocortisone—gout	6.82e-05	0.000242	CcSEcCtD
Thalidomide—Shock—Prednisone—gout	6.78e-05	0.000241	CcSEcCtD
Thalidomide—Nervous system disorder—Prednisone—gout	6.75e-05	0.00024	CcSEcCtD
Thalidomide—Tachycardia—Prednisone—gout	6.72e-05	0.000239	CcSEcCtD
Thalidomide—Skin disorder—Prednisone—gout	6.69e-05	0.000238	CcSEcCtD
Thalidomide—Hyperhidrosis—Prednisone—gout	6.66e-05	0.000236	CcSEcCtD
Thalidomide—Asthenia—Hydrocortisone—gout	6.64e-05	0.000236	CcSEcCtD
Thalidomide—Anorexia—Prednisone—gout	6.56e-05	0.000233	CcSEcCtD
Thalidomide—Pruritus—Hydrocortisone—gout	6.55e-05	0.000233	CcSEcCtD
Thalidomide—CYP2C19—Metabolism—PRPS2—gout	6.52e-05	0.00163	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PRPS1—gout	6.52e-05	0.00163	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—HPRT1—gout	6.52e-05	0.00163	CbGpPWpGaD
Thalidomide—Hypersensitivity—Methylprednisolone—gout	6.41e-05	0.000227	CcSEcCtD
Thalidomide—Diarrhoea—Hydrocortisone—gout	6.33e-05	0.000225	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Prednisone—gout	6.27e-05	0.000223	CcSEcCtD
Thalidomide—Dizziness—Prednisolone—gout	6.27e-05	0.000223	CcSEcCtD
Thalidomide—Asthenia—Methylprednisolone—gout	6.24e-05	0.000222	CcSEcCtD
Thalidomide—CYP1A2—Metabolism—BCKDHA—gout	6.24e-05	0.00155	CbGpPWpGaD
Thalidomide—Insomnia—Prednisone—gout	6.23e-05	0.000221	CcSEcCtD
Thalidomide—Paraesthesia—Prednisone—gout	6.18e-05	0.00022	CcSEcCtD
Thalidomide—Pruritus—Methylprednisolone—gout	6.15e-05	0.000218	CcSEcCtD
Thalidomide—Dizziness—Hydrocortisone—gout	6.12e-05	0.000217	CcSEcCtD
Thalidomide—Dyspepsia—Prednisone—gout	6.06e-05	0.000215	CcSEcCtD
Thalidomide—CYP2C19—Biological oxidations—POMC—gout	6.05e-05	0.00151	CbGpPWpGaD
Thalidomide—Decreased appetite—Prednisone—gout	5.99e-05	0.000213	CcSEcCtD
Thalidomide—Rash—Prednisolone—gout	5.98e-05	0.000212	CcSEcCtD
Thalidomide—Dermatitis—Prednisolone—gout	5.97e-05	0.000212	CcSEcCtD
Thalidomide—Diarrhoea—Methylprednisolone—gout	5.95e-05	0.000211	CcSEcCtD
Thalidomide—CYP2C9—Metabolism—PRPS2—gout	5.95e-05	0.00148	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—HPRT1—gout	5.95e-05	0.00148	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PRPS1—gout	5.95e-05	0.00148	CbGpPWpGaD
Thalidomide—Fatigue—Prednisone—gout	5.94e-05	0.000211	CcSEcCtD
Thalidomide—Headache—Prednisolone—gout	5.94e-05	0.000211	CcSEcCtD
Thalidomide—Constipation—Prednisone—gout	5.89e-05	0.000209	CcSEcCtD
Thalidomide—Vomiting—Hydrocortisone—gout	5.88e-05	0.000209	CcSEcCtD
Thalidomide—Rash—Hydrocortisone—gout	5.84e-05	0.000207	CcSEcCtD
Thalidomide—Dermatitis—Hydrocortisone—gout	5.83e-05	0.000207	CcSEcCtD
Thalidomide—Headache—Hydrocortisone—gout	5.8e-05	0.000206	CcSEcCtD
Thalidomide—Dizziness—Methylprednisolone—gout	5.75e-05	0.000204	CcSEcCtD
Thalidomide—Feeling abnormal—Prednisone—gout	5.67e-05	0.000202	CcSEcCtD
Thalidomide—Gastrointestinal pain—Prednisone—gout	5.63e-05	0.0002	CcSEcCtD
Thalidomide—Nausea—Prednisolone—gout	5.63e-05	0.0002	CcSEcCtD
Thalidomide—Vomiting—Methylprednisolone—gout	5.53e-05	0.000196	CcSEcCtD
Thalidomide—CYP2C9—Biological oxidations—POMC—gout	5.51e-05	0.00137	CbGpPWpGaD
Thalidomide—Nausea—Hydrocortisone—gout	5.5e-05	0.000195	CcSEcCtD
Thalidomide—Rash—Methylprednisolone—gout	5.48e-05	0.000195	CcSEcCtD
Thalidomide—Dermatitis—Methylprednisolone—gout	5.48e-05	0.000194	CcSEcCtD
Thalidomide—Urticaria—Prednisone—gout	5.47e-05	0.000194	CcSEcCtD
Thalidomide—Headache—Methylprednisolone—gout	5.45e-05	0.000193	CcSEcCtD
Thalidomide—Abdominal pain—Prednisone—gout	5.44e-05	0.000193	CcSEcCtD
Thalidomide—Body temperature increased—Prednisone—gout	5.44e-05	0.000193	CcSEcCtD
Thalidomide—Nausea—Methylprednisolone—gout	5.16e-05	0.000183	CcSEcCtD
Thalidomide—CYP1A2—Metabolism—PRPS1—gout	5.08e-05	0.00127	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—HPRT1—gout	5.08e-05	0.00127	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PRPS2—gout	5.08e-05	0.00127	CbGpPWpGaD
Thalidomide—Hypersensitivity—Prednisone—gout	5.07e-05	0.00018	CcSEcCtD
Thalidomide—Asthenia—Prednisone—gout	4.94e-05	0.000175	CcSEcCtD
Thalidomide—Pruritus—Prednisone—gout	4.87e-05	0.000173	CcSEcCtD
Thalidomide—Diarrhoea—Prednisone—gout	4.71e-05	0.000167	CcSEcCtD
Thalidomide—CYP1A2—Biological oxidations—POMC—gout	4.71e-05	0.00117	CbGpPWpGaD
Thalidomide—Dizziness—Prednisone—gout	4.55e-05	0.000162	CcSEcCtD
Thalidomide—Vomiting—Prednisone—gout	4.38e-05	0.000155	CcSEcCtD
Thalidomide—Rash—Prednisone—gout	4.34e-05	0.000154	CcSEcCtD
Thalidomide—Dermatitis—Prednisone—gout	4.34e-05	0.000154	CcSEcCtD
Thalidomide—Headache—Prednisone—gout	4.31e-05	0.000153	CcSEcCtD
Thalidomide—PTGS1—Metabolism—ABCG2—gout	4.19e-05	0.00104	CbGpPWpGaD
Thalidomide—Nausea—Prednisone—gout	4.09e-05	0.000145	CcSEcCtD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—POMC—gout	4.03e-05	0.001	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—ABCG2—gout	3.32e-05	0.000829	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—gout	3.2e-05	0.000797	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—ABCG2—gout	3.13e-05	0.00078	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—ABCG2—gout	3.12e-05	0.000778	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—ABCG2—gout	2.95e-05	0.000735	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—POMC—gout	2.84e-05	0.000707	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—POMC—gout	2.53e-05	0.00063	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—ABCG2—gout	2.41e-05	0.000602	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—POMC—gout	2.4e-05	0.000597	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—gout	2.32e-05	0.000579	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—ABCG2—gout	2.2e-05	0.000549	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—gout	2.12e-05	0.000528	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—ABCG2—gout	1.88e-05	0.000469	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—gout	1.81e-05	0.000451	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—POMC—gout	1.79e-05	0.000447	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—POMC—gout	1.42e-05	0.000355	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—POMC—gout	1.34e-05	0.000334	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—POMC—gout	1.34e-05	0.000333	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—POMC—gout	1.26e-05	0.000315	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—POMC—gout	1.03e-05	0.000258	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—POMC—gout	9.43e-06	0.000235	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—POMC—gout	8.06e-06	0.000201	CbGpPWpGaD
